Last ¥1,787 JPY
Change Today -5.00 / -0.28%
Volume 275.1K
4508 On Other Exchanges
Symbol
Exchange
Berlin
Tokyo
OTC US
OTC US
OTC US
As of 1:00 AM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for mitsubishi tanabe pharma (4508)

Year over year, Mitsubishi Tanabe Pharma Corporation has seen revenues remain relatively flat (¥419.2B JPY to ¥412.7B JPY), though the company was able to grow net income from ¥41.9B JPY to ¥45.4B JPY. A reduction in the percentage of sales devoted to selling, general and administrative costs from 25.20% to 24.64% was a key component in the bottom line growth in the face of flat revenues.
View Income Statement In U.S. Dollar
Currency in
Millions of Japanese Yens
As of:Mar 31
2011
JPY
Mar 31
2012
JPY
Mar 31
2013
JPY
Mar 31
2014
JPY
4 Year
Trend
Revenues409,540.0407,156.0419,179.0412,675.0
TOTAL REVENUES409,540.0407,156.0419,179.0412,675.0
Cost of Goods Sold154,564.0152,284.0166,388.0169,363.0
GROSS PROFIT254,976.0254,872.0252,791.0243,312.0
Selling General & Admin Expenses, Total100,484.0103,466.0105,639.0101,685.0
R&D Expenses65,784.070,241.066,530.070,405.0
Depreciation & Amortization, Total11,919.011,791.011,584.012,103.0
Other Operating Expenses205.0331.070.0--
OTHER OPERATING EXPENSES, TOTAL178,392.0185,829.0183,823.0184,193.0
OPERATING INCOME76,584.069,043.068,968.059,119.0
Interest Expense-15.0-18.0-70.0-90.0
Interest and Investment Income2,342.02,352.02,489.02,375.0
NET INTEREST EXPENSE2,327.02,334.02,419.02,285.0
Income (Loss) on Equity Investments259.0162.0369.0595.0
Currency Exchange Gains (Loss)-1,422.0-1,507.0-1,137.02,527.0
Other Non-Operating Income (Expenses)-661.0-870.0-804.0-2,653.0
EBT, EXCLUDING UNUSUAL ITEMS77,087.069,162.069,815.061,873.0
Gain (Loss) on Sale of Investments-7,861.0-2,197.0287.02,735.0
Gain (Loss) on Sale of Assets-451.0305.02,534.0994.0
Other Unusual Items, Total-4,674.0-3,482.0-4,945.06,839.0
Other Unusual Items-3,867.0-148.0-4,189.08,211.0
EBT, INCLUDING UNUSUAL ITEMS64,101.063,788.067,691.072,441.0
Income Tax Expense26,503.024,528.025,738.027,032.0
Minority Interest in Earnings149.0-246.0-61.0-16.0
Earnings from Continuing Operations37,598.039,260.041,953.045,409.0
NET INCOME37,747.039,014.041,892.045,393.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS37,747.039,014.041,892.045,393.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS37,747.039,014.041,892.045,393.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4508:JP ¥1,787.00 JPY -5.00

4508 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4508.
View Industry Companies
 

Industry Analysis

4508

Industry Average

Valuation 4508 Industry Range
Price/Earnings 18.5x
Price/Sales 2.2x
Price/Book 1.2x
Price/Cash Flow 14.8x
TEV/Sales 1.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MITSUBISHI TANABE PHARMA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.